Phase II study of n-methylformamide (NSC 3051) and...

Investigational New Drugs 1990 / 05 Vol. 8; Iss. 2

Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer

David S. Ettinger, Dianne M. Finkelstein, Martin D. Abeloff, Yuang-Chi Chang, Thomas J. Smith, Martin M. Oken, John C. Ruckdeschel
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Language:
english
Pages:
3
DOI:
10.1007/bf00177255
Date:
May, 1990
File:
PDF, 171 KB
english, 1990
Conversion to is in progress
Conversion to is failed